Ra capital sells Vor Biopharma (VOR) shares worth $10.3 million
PositiveFinancial Markets

Ra Capital has successfully sold shares of Vor Biopharma for $10.3 million, marking a significant move in the investment landscape. This sale not only reflects Ra Capital's strategic financial decisions but also highlights the growing interest in biotech companies like Vor Biopharma. Such transactions can influence market trends and investor confidence, making it an important development to watch.
— Curated by the World Pulse Now AI Editorial System











